Evidence map›Paper›PMID 38453517›Full record

ArticleBMJ global health2024

The impact of policy and policy communication on COVID-19 vaccination inequalities among Venezuelan refugees and migrants in Colombia: a comparative cross-sectional interrupted time-series analysis.

Wilson Gomez, Julián A Fernández-Niño, José Rafael Guillén, Megan Stevenson, Jennifer Ortíz, Miguel Ángel Barriga Talero, Jhon Jairo López, Ricardo Luque Núñez, Paul Spiegel, Kathleen R Page and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Last mile at the center of immunization delivery.Frontiers in epidemiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Wilson Gomez *Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID http://orcid.org/0009-0008-3751-7907
Julián A Fernández-Niño *Center for Humanitarian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
José Rafael GuillénRed Somos, Bogotá, Colombia.
Megan StevensonCenter for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Jennifer OrtízRed Somos, Bogotá, Colombia.
Miguel Ángel Barriga TaleroRed Somos, Bogotá, Colombia.
Jhon Jairo LópezRed Somos, Bogotá, Colombia.
Ricardo Luque NúñezGovernment of Colombia Ministry of Health and Social Protection, Bogotá, Colombia.
Paul SpiegelCenter for Humanitarian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID http://orcid.org/0000-0002-6158-6661
Kathleen R PageCenter for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Jhon Fredy Ramirez CorreaRed Somos, Bogotá, Colombia.
Damary Martínez PorrasRed Somos, Bogotá, Colombia.
Andrea L WirtzCenter for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA awirtz1@jhu.edu.ORCID http://orcid.org/0000-0002-2063-1534
Johns Hopkins University · USMinistry of Health and Social Protection · CO

Funding

AZT IN THE TREATMENT OF HIV ASSOCIATED DEMENTIA AND NEUROMUSCULAR DISORDERSZ01CC002000 · CC · CENTERS FOR DISEASE CONTROL AND PREV · PI SEVER, J L · 1988 to 1988
–
6 · The paper itself

Abstract

introductionEquitable access to vaccines for migrants and refugees is necessary to ensure their right to health and to achieve public health goals of reducing vaccine-preventable illness. Public health policies require regulatory frameworks and communication to effect uptake of effective vaccines among the target population. In Colombia, the National COVID-19 Vaccination Plan implicitly included Venezuelan refugees and migrants; however, initial communication of the policy indicated that vaccine availability was restricted to people with regular migration status. We estimated the impact of a public announcement, which clarified access for refugees and migrants, on vaccination coverage among Venezuelans living in Colombia.

methodsBetween 30 July 2021 and 5 February 2022, 6221 adult Venezuelans participated in a cross-sectional, population-based health survey. We used a comparative cross-sectional time-series analysis to estimate the effect of the October 2021 announcement on the average biweekly change in COVID-19 vaccine coverage of Venezuelans with regular and irregular migration status.

results71% of Venezuelans had an irregular status. The baseline (preannouncement) vaccine coverage was lower among people with an irregular status but increased at similar rates as those with a regular status. After the announcement, there was a level change of 14.49% (95% CI: 1.57 to 27.42, p=0.03) in vaccination rates among individuals with irregular migration status with a 4.61% increase in vaccination rate per biweekly period (95% CI: 1.71 to 7.51, p=0.004). By February 2022, there was a 26.2% relative increase in vaccinations among individuals with irregular migration status compared with what was expected without the announcement.

conclusionWhile there was no policy change, communication clarifying the policy drastically reduced vaccination inequalities across migration status. Lessons can be translated from the COVID-19 pandemic into more effective global, regional and local public health emergency preparedness and response to displacement.

Indexed as

COVID-19COVID-19 VaccinesRefugeesSouth American PeopleTransients and MigrantsAdultColombiaCommunicationCross-Sectional StudiesHealth PolicyHumansPandemicsVaccinationCOVID-19 VaccinesCOVID-19Health policies and all other topicsVaccines

Identifiers

PMID38453517
PMCPMC10921509
OpenAlexW4392626911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.